Literature DB >> 20664692

PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1.

Juan Wang1, Shiqiang Li, Xueshan Xiao, Panfeng Wang, Xiangming Guo, Qingjiong Zhang.   

Abstract

PURPOSE: To detect paired box gene 3 (PAX3) mutations and associated phenotypes in Chinese patients with Waardenburg syndrome type 1 (WS1).
METHODS: Five unrelated families with suspected WS1 were selected from our Genomic DNA Repository for Hereditary Eye Diseases. The coding and adjacent intronic regions of PAX3 were amplified by polymerase chain reaction and the amplicons were then analyzed by cycle sequencing. Variations detected were further evaluated in available family members as well as one hundred controls with heteroduplex-single strand conformational polymorphism (heteroduplex-SSCP) analysis and/or clone sequencing.
RESULTS: Three novel and two known mutations in PAX3 were detected in five patients, respectively: c.567_586+17del (p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly), c.456_459dupTTCC (p.Ile154PhefsX162), c.795_800delCTGGTT (p.Trp266_Phe267del), c.799T>A (p.Phe267Ile), and c.667C>T (p.Arg223X). Two novel mutations proved to be de novo as their parents did not carry the mutations. All five patients with PAX3 mutations had dystopia canthorum and different iris color and fundi between their two eyes. However, none had white forelock, skin hypopigmentation, and deafness.
CONCLUSIONS: Our findings expand the frequency and spectrum of PAX3 mutations and ethnic-related phenotypes in Chinese patients with WS1. De novo mutations in PAX3 have not been reported before.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664692      PMCID: PMC2901192     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


Introduction

Waardenburg syndrome (WS) is an inherited disorder characterized by varying degrees of hearing loss and pigmentary anomalies affecting the eye, hair, and skin [1-6]. WS is clinically heterogeneous and has been classified into four major types and 10 subtypes as listed in Table 1 [5,7-17]. WS type 1 (WS1, OMIM 193500) and type 2 (WS2) are more common than type 3 (WS3) and type 4 (WS4). Overall, the syndrome affects perhaps 1 in 42,000 people [6].
Table 1

Classification of Waardenburg syndrome.




Phenotypes


TypesOMIMInheritance12345Genes or lociReference
WS1
193500
AD
+
+/−*
+
-
-
PAX3
[8]
WS2
 
 
+
+/−**
-
-
-
 
 
WS2A
193510
AD
+
+
-
-
-
MITF
[9]
WS2B
600193
AD
+
+
-
-
-
1p21-p13.3
[17]
WS2C
606662
AD
+
+
-
-
-
8p23
[10]
WS2D
608890
AR
+
+
-
-
-
SNAI2
[11]
WS2E
611584
AD
+
+
-
-
-
SOX10
[12]
WS3
148820
AD or AR
+
+
+
+
-
PAX3
[13]
WS4
 
 
+
+
-
-
+
 
 
WS4A
277580
AR or AD
+
+/−
-
-
+
EDNRB
[14]
WS4B
613265
AR or AD
+
+
-
-
+
EDN3
[15]
WS4C613266AD++--+SOX10[16]

Note: Phenotype 1: pigmentary disturbance of skin, hair and iris; Phenotype 2: Deafness; Phenotype 3: dystopia canthorum; Phenotype 4: upper limb abnormalities; Phenotype 5: aganglionic megacolon. The asterisk indicates presence in about 1/5 cases and the double asterisk indicates presence in about 3/4 cases.

Note: Phenotype 1: pigmentary disturbance of skin, hair and iris; Phenotype 2: Deafness; Phenotype 3: dystopia canthorum; Phenotype 4: upper limb abnormalities; Phenotype 5: aganglionic megacolon. The asterisk indicates presence in about 1/5 cases and the double asterisk indicates presence in about 3/4 cases. Except for auditory-pigmentary disorder, dystopia canthorum is the typical phenotype of WS1 (Table 1). Mutations in the paired box gene 3 (PAX3, OMIM 606597) have been identified to be responsible for WS1 [18,19]. PAX3 encodes a member of the mammalian PAX family of transcription factors, which contains two highly conserved domains for DNA binding, paired box domain and paired-type homeodomain [20]. Alternative splicing of PAX3 results in several different-length transcripts, of which the longest transcript contains 10 exons, and consequent proteins with distinct carboxyl termini [21]. PAX3 plays a regulatory role in the early embryonic development of the pigment system [22] and is required to expand a pool of committed melanoblasts or restricted progenitor cells early in development [23]. Heterozygous mutations in PAX3 have been reported in familial and sporadic WS1, while heterozygous or homozygous mutations have been detected in patients with WS3 [8,13,24,25]. Although many mutations have been identified in Caucasians, several cases have been determined in the Chinese population [26,27]. Fundus changes for WS1 patients with PAX3 mutations have not been reported. In the present study, five mutations in PAX3, including three novel ones and two known ones, were identified in five unrelated Chinese families with WS1. All patients with the 5 mutations presented dystopia canthorum and different colors of the irises and fundi but none of those showed visible pigmentary changes on their hair and skin, indicating an ethnic specific phenotypes.

Methods

Patients

Five unrelated patients were recruited from our Pediatric and Genetic Eye Clinic, Zhongshan Ophthalmic Center, Guangzhou, P.R. China. Diagnosis of WS1 was based on criteria previously described [4,28]. Informed consent conforming to the tenets of the Declaration of Helsinki and following the Guidance of Sample Collection of Human Genetic Diseases (National 863-Plan) by the Ministry of Public Health of China was obtained from participating individuals before the study. All participants received detailed ophthalmological examinations performed by ophthalmologists (Q.Z. or X.G.). Unrelated controls (100) were collected from normal volunteers. This study was approved by the Institutional Review Board of Zhongshan Ophthalmic Center.

Variation analysis

Genomic DNA was isolated from venous leukocytes. Genomic fragments encompassing coding regions and adjacent intronic regions of PAX3 were amplified by polymerase chain reaction (PCR), using eleven primer pairs (PAX3: NCBI human genome build 36.1, NC_000002.11, NM_181459.2, NP_852124.1), including previously reported primers for exons 1–9 [26] and two new primer pairs for exon 10 (Table 2). The amplicons from individual exon were purified and analyzed by cycle sequencing with ABI BigDye Terminator Cycle Sequencing Kit v3.1 (ABI Applied Biosystems, Foster City, CA) on an automatic DNA sequencer (ABI 3100 Genetic Analyzer, Applied Biosystems). Sequencing results from patients as well as the consensus sequences from the NCBI Human Genome Database were imported into the SeqManII program of the Lasergene package (DNAStar Inc., Madison, WI) and aligned to identify variations. Each variation was confirmed by bidirectional sequencing. Variations were named following the nomenclature recommended by the Human Genomic Variation Society (HGVS).
Table 2

Primers for amplifying and sequencing PAX3 genomic fragments.

ExonForward Primers(5′-3′)Reverse Primers(5′-3′)Product size (bp)Annealing temperature (°C)
PAX3-ex1
TCACCACAGGAGGAGACTCA
GAGGCCCTCCCTTACCTTC
472
60
PAX3-ex2
TACGTGCTGCTGTTCTTTGC
TTACGCACCTTCACAAACCTC
442
60
PAX3-ex3
TCTGGTCTGCCCCTTTCTAA
ATTGGGGTGATTACGTCTGG
388
60
PAX3-ex4
GCTGGAGAAGGATGAGGATG
CTCCAAGTGACCCAGCAAGT
351
60
PAX3-ex5
TGTCTTGCAGTCGGAGAGAG
GGTGGACTTCTGTGTGTCGT
492
60
PAX3-ex6
AATTCGCCCAAACAACACA
CAGAGAAATCGCCTGGAAGT
368
60
PAX3-ex7
TGGCGATGAACTTTTGCAC
GGGTGGAGAGAAAGGAAACC
451
60
PAX3-ex8
TCGTCGGGCATGATGTAATA
AGGAGAAATTGCCCCCTAAA
359
60
PAX3-ex9
GAATTGTCCCAGCATGACCT
TGCTCCAGGTCTTCCTCTTC
311
62
PAX3-ex10a
ACTGGCCCTGTTTCTGGTCT
TGGCAAACATCACTGCACTC
943
60
PAX3-ex10bCCAGTTCACATTTATTTGGCTCATAGAAAGGGTCCAC88760
Any variation detected by sequence analysis was further evaluated in 100 controls by heteroduplex-SSCP analysis. In addition, one multiple-nucleotide deletion was further analyzed by clone sequencing, using the method we described previously [29]. NNSPLICE version 0.9 was used to predict splice sites.

Results

Clinical phenotype

The most significant sign in all five unrelated patients is different colors between two eyes, which resulted from heterochromia iridis (Figure 1, Table 3). All patients had dystopia canthorum (Figure 1). Ocular fundus examination revealed different colors between two fundi (Figure 2), which have not been described before. In all 5 patients the eye with generalized iris hypopigmentation also had mild retinal hypopigmentation. In the eyes with pigmentary changes, however, the fundus vessel distribution, macular architectural and visual acuity seemed to be normal (Figure 2 and Table 3). None of the 5 patients had pigmentary changes on their skin, hair, eyebrows, and eyelashes, which are the common signs in Caucasian patients. Deafness was not observed in three patients while the hearing function could not be measured in the other two babies. Anomalies on limb development were not observed in all 5 patients.
Figure 1

Photographs of eyes from WS1 patients and controls. A: Baby with normal iris pigmentation and normal facial characteristics. B: 15-month-old girl (II:1 from family A in Figure 3) with dystopia canthorum, heterochromia iridis, broad nasal root, and a horizontal distance between the inner canthi of 28 mm. C: Normal adult (I:2 from family A). D, E: Adult II:1 from family E showed dystopia canthorum, heterochromia iridis (left iris).

Table 3

Clinical findings in patients from Families A-E and mutations identified in PAX3.

 
 
 
Visual acuity
 
 
 
 
 
 
 
IDSexAge (yrs)ODOSMutationEffectDifferently colored eyesFundus hypopigmentationDystopia canthorumDeafnessFamily history
A-II:1
F
1
NA
NA
c.567_586+17del
p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly
OS
OS
Yes
NA
No
B-II:1
M
0.6
NA
NA
c.456_459dupTTCC
p.Ile154PhefsX162
OS
OS
Yes
NA
No
C-II:1
M
7
1.00
0.90
c.795_800delCTGGTT
p.Trp266_Phe267del
OS
OS
Yes
No
No
D-IV:1
M
6
0.90
1.00
c.799T>A
p.Phe267Ile
OD
OD
Yes
No
Yes
E-II:1F231.501.50c.667C>Tp.Arg223XOSOSYesNoNo

Note: NA: Not available because they are too young. None of the 5 probands had white forelock and skin hypopigmentation.

Figure 2

Photographs of fundi from WS1 patients with PAX3 mutations. Fundus photos were taken from the right (OD) and the left (OS) eyes of two patients, II:1 from family C and II:1 from family E. The colors of fundus photos were different between two eyes in both patients, where mild retinal hypopigmentation was demonstrated in the left eyes of both patients. The difference of fundus colors between C_II:1 and E_II:1 is of no clinical significance as different fundus cameras were used. Except for hypopigmentation, the fundus structure was comparatively normal in the patients.

Photographs of eyes from WS1 patients and controls. A: Baby with normal iris pigmentation and normal facial characteristics. B: 15-month-old girl (II:1 from family A in Figure 3) with dystopia canthorum, heterochromia iridis, broad nasal root, and a horizontal distance between the inner canthi of 28 mm. C: Normal adult (I:2 from family A). D, E: Adult II:1 from family E showed dystopia canthorum, heterochromia iridis (left iris).
Figure 3

Pedigrees and sequence chromatography. Black filled symbols represented individuals affected with WS1 in each family. Arrow indicated the proband in each family. A: Clone sequencing demonstrated a c.567_586+17del mutation in Family A. For the other four families, bidirectional sequencing results were shown for the regions with variations. Underline below the sequence highlighted the codon affected by the mutation. Gel electrophoresis band patterns below the pedigrees of families A, B, and C were the results of heteroduplex-SSCP analysis, which demonstrated the presence and absence of three novel mutations in other family members. The c.456_459dupTTCC and c.795_800delCTGGTT mutations in the probands from families B and C were not detected in their parents, suggesting de novo mutations. The c.567_586+17del mutation in Family A was not present in the patient’s father but sample from her mother was not available. For families D and E, genomic samples from other family members were not available.

Note: NA: Not available because they are too young. None of the 5 probands had white forelock and skin hypopigmentation. Photographs of fundi from WS1 patients with PAX3 mutations. Fundus photos were taken from the right (OD) and the left (OS) eyes of two patients, II:1 from family C and II:1 from family E. The colors of fundus photos were different between two eyes in both patients, where mild retinal hypopigmentation was demonstrated in the left eyes of both patients. The difference of fundus colors between C_II:1 and E_II:1 is of no clinical significance as different fundus cameras were used. Except for hypopigmentation, the fundus structure was comparatively normal in the patients.

Variation detection

In the 5 patients, five heterozygous mutations in PAX3 were detected, including c.567_586+17del (p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly), c.456_459dupTTCC (p.Ile154PhefsX162), c.795_800delCTGGTT (p.Trp266_Phe267del), c.799T>A (p.Phe267Ile), and c.667C>T (p.Arg223X; Table 3, Figure 3). The first three mutations were novel and, therefore, were further confirmed by heteroduplex-SSCP analysis (Figure 3). The other two mutations were known mutations. All five mutations were absent in 100 normal controls based on heteroduplex-SSCP analysis (data not shown). Pedigrees and sequence chromatography. Black filled symbols represented individuals affected with WS1 in each family. Arrow indicated the proband in each family. A: Clone sequencing demonstrated a c.567_586+17del mutation in Family A. For the other four families, bidirectional sequencing results were shown for the regions with variations. Underline below the sequence highlighted the codon affected by the mutation. Gel electrophoresis band patterns below the pedigrees of families A, B, and C were the results of heteroduplex-SSCP analysis, which demonstrated the presence and absence of three novel mutations in other family members. The c.456_459dupTTCC and c.795_800delCTGGTT mutations in the probands from families B and C were not detected in their parents, suggesting de novo mutations. The c.567_586+17del mutation in Family A was not present in the patient’s father but sample from her mother was not available. For families D and E, genomic samples from other family members were not available. The c.567_586+17del mutation was identified in a baby from Family A (A-II:1). Direct sequencing revealed a heterozygous variation involving multiple nucleotides in exon 4 region. Cloning sequencing revealed a 37 bp deletion affecting both exon 4 and intron 4 (Figure 3A). A new splice site is predicted to be created downstream by NNSPLICE. The encoded protein would be truncated. The c.456_459dupTTCC and c.795_800delCTGGTT mutations were only present in the probands (Figure 3, B-II:1, C-II:1) but not in their parents, demonstrating de novo mutations that have been rarely reported in PAX3.

Discussion

In this study, three novel and two known mutations in PAX3 were identified in five unrelated Chinese patients. The three novel mutations would result in frameshift or inframe deletion if transcribed and translated, suggesting putative disease-causing. Unilateral sapphire iris with pink pupil and retinal depigmentation as well as dystopia canthorum without other abnormalities suggested a diagnosis of WS1. Of the five PAX3 mutations, three were novel (c.567_586+17del, c.456_459dupTTCC and c.795_800delCTGGTT) and the other two were previously reported (c.799T>A and c.667C>T) [30,31]. Two novel mutations, c.456_459dupTTCC and c.795_800delCTGGTT, were proved to be de novo as their parents did not carry the mutations, suggesting that natural occurring new mutations in PAX3 of the Chinese population is not uncommon. Based on available information, de novo mutations in PAX3 have rarely been mentioned before. Three of the five mutations, c.567_586+17del (p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly), c.456_459dupTTCC (p.Ile154PhefsX162) and c.667C>T (p.Arg223X), are predicted to encode premature truncated proteins affecting the paired-type homeodomain [20]. The other two mutations, c.795_800delCTGGTT (p.Trp266_Phe267del) and c.799T>A (p.Phe267Ile), would also affect the paired-type homeodomain, if translated. Clinical manifestation of the 5 Chinese patients with PAX3 mutations is consistent with the phenotypes of WS1. However, pigmentary changes on skin, hair, eyebrows, and eyelashes are absent in these Chinese patients, indicating an ethnic specific variations in clinical expression. Fundus hypopigmentation in WS1 patients have been demonstrated in the Chinese patients. Although fundus hypopigmentation was recorded in WS in previous reports, it has not been described in WS1 patients with PAX3 mutations before. Understanding the typical and atypical phenotypes of Chinese WS1 patients is of clinical importance as such patients may be misdiagnosed as unilateral ocular albinism, especially since mild dystopia canthorum is not uncommon in Southern Chinese population.
  30 in total

Review 1.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

2.  A novel mutation of PAX3 in a Chinese family with Waardenburg syndrome.

Authors:  Wei Qin; Anli Shu; Xueqing Qian; Jianjun Gao; Qinghe Xing; Juan Zhang; Yonglan Zheng; Xingwang Li; Sheng Li; Guoyin Feng; Lin He
Journal:  Mol Vis       Date:  2006-08-28       Impact factor: 2.367

3.  A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness.

Authors:  P J WAARDENBURG
Journal:  Am J Hum Genet       Date:  1951-09       Impact factor: 11.025

4.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 5.  Molecular basis of congenital hypopigmentary disorders in humans: a review.

Authors:  R E Boissy; J J Nordlund
Journal:  Pigment Cell Res       Date:  1997 Feb-Apr

6.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.

Authors:  M Tassabehji; V E Newton; A P Read
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes.

Authors:  L A Farrer; K S Arnos; J H Asher; C T Baldwin; S R Diehl; T B Friedman; J Greenberg; K M Grundfast; C Hoth; A K Lalwani
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

8.  Mutations in PAX3 associated with Waardenburg syndrome type I.

Authors:  C T Baldwin; N R Lipsky; C F Hoth; T Cohen; W Mamuya; A Milunsky
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome).

Authors:  P Edery; T Attié; J Amiel; A Pelet; C Eng; R M Hofstra; H Martelli; C Bidaud; A Munnich; S Lyonnet
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

10.  A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease.

Authors:  E G Puffenberger; K Hosoda; S S Washington; K Nakao; D deWit; M Yanagisawa; A Chakravart
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  7 in total

Review 1.  Relationship between neural crest cell specification and rare ocular diseases.

Authors:  Monica Akula; Jeong Won Park; Judith A West-Mays
Journal:  J Neurosci Res       Date:  2018-04-16       Impact factor: 4.164

Review 2.  Genetic basis of hearing loss in Spanish, Hispanic and Latino populations.

Authors:  Rahul Mittal; Amit P Patel; Desiree Nguyen; Debbie R Pan; Vasanti M Jhaveri; Jason R Rudman; Arjuna Dharmaraja; Denise Yan; Yong Feng; Prem Chapagain; David J Lee; Susan H Blanton; Xue Zhong Liu
Journal:  Gene       Date:  2018-01-10       Impact factor: 3.688

3.  A novel mutation of the MITF gene in a family with Waardenburg syndrome type 2: A case report.

Authors:  Yunfang Shi; Xiaozhou Li; Duan Ju; Yan Li; Xiuling Zhang; Ying Zhang
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

4.  A Novel Frameshift Variant of the MITF Gene in a Chinese Family with Waardenburg Syndrome Type 2.

Authors:  Ying Li; Yajuan Xu; Genxia Li; Kang Chen; Haiyang Yu; Jinshuang Gao; Weifang Tian; Yuehua Liu; Pingping Liu; Linlin Zhang; Zhan Zhang
Journal:  Mol Syndromol       Date:  2021-06-14

5.  Application of a New Genetic Deafness Microarray for Detecting Mutations in the Deaf in China.

Authors:  Hong Wu; Yong Feng; Lu Jiang; Qian Pan; Yalan Liu; Chang Liu; Chufeng He; Hongsheng Chen; Xueming Liu; Chang Hu; Yiqiao Hu; Lingyun Mei
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

6.  A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1.

Authors:  Filiz Hazan; A Taylan Ozturk; Hamit Adibelli; Nurettin Unal; Ajlan Tukun
Journal:  Mol Vis       Date:  2013-01-29       Impact factor: 2.367

7.  Waardenburg syndrome type I: Dental phenotypes and genetic analysis of an extended family.

Authors:  L Sólia-Nasser; S-N de Aquino; L-M R Paranaíba; A Gomes; P Dos-Santos-Neto; R-D Coletta; A-F Cardoso; A-C Frota; H Martelli-Júnior
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.